haematology
Blood cancers

No role for routine blood tests in detecting relapse of lymphoma

Routine blood tests should not be used for surveillance of patients in remission from aggressive lymphoma because they have little value in detecting relapse, Victorian oncologists say. A study of 346 patients in remission from aggressive lymphoma found that none of the routine lab tests – including erythrocyte sedimentation rate (ESR), lactate dehydrogenease (LDH), Full ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic